Height as a risk factor for osteosarcoma

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 6, 2005, Pages 314-318

  Longhi, Alessandra ^a   Pasini, Andrea ^b   Cicognani, Alessandro ^b   Baronio, Federico ^b   Pellacani, Andrea ^a   Baldini, Nicola ^a   Bacci, Gaetano ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone; Growth; Height; Osteosarcoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

ADOLESCENT; ADULT; AGE FACTORS; BODY HEIGHT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; OSTEOSARCOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS;

EID: 21244436009     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000169251.57611.8e     Document Type: Article

References (32)

1. Malawer MM, Link MP, Donaldson SS. Sarcomas of bone. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology, 3rd ed. Philadelphia: JB Lippincott, 1989:1418-1468.
2. Kramer S, Meadows AT, Jarret P, et al. The incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst. 1983;70:49-55.
3. Fuchs B, Pritchard DJ. Etiology of osteosarcoma. Clin Orthop. 2002;397: 40-52.
4. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643-646.
5. Malkin D, Li FP, Strong LC, et al. Germline p53 mutations in a familial syndrome of breast cancer, sarcoma, and other neoplasms. Science. 1990; 250:1233-1238.
6. German J. Bloom's syndrome: the first 100 cancers. Cancer Genet Cytogenet. 1997;93:100-106.
7. Wang LL, Gannavaparu A, Kozinets CA, et al. Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst. 2003;95:669-674.
8. Withrow SJ, Powers BE, Straw RC, et al. Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop. 1991;270:159-168.
9. Tjalma RA. Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst. 1966;36:1137-1150.
10. Fraumeni JF. Stature and malignant tumors of bones in childhood and adolescence. Cancer. 1967;20:967-973.
11. Scranton PE Jr, De Cicco FA, Toten RS, et al. Prognostic factors in osteosarcoma: a review of 20 years' experience at the University of Pittsburgh Health Center Hospitals. Cancer. 1975;36:2179-2191.
12. Gelberg KH, Fitzgerald EF, Hwang S, et al. Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol. 1997;26:272-278.
13. Brostrom LA, Adamson U, Filipsson R, et al. Longitudinal growth and dental development in osteosarcoma patients. Acta Orthop Scand. 1980; 51:755-759.
14. Baserga R. Oncogens and the strategy of growth factors. Cell. 1994;79: 927-930.
15. Pollak MN, Polychronakos C, Richard M. Insulin-like growth factor I: a potent mitogen for human osteogenic sarcoma. J Natl Cancer Inst. 1990; 82:301-305.
16. Pollak M, Stern AW, Richard M, et al. Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy. J Natl Cancer Inst. 1992;84: 966-971.
17. Kappel CC, Velez-Yanguas MC, Hirschfeld S, et al. Human osteosarcoma cell lines are dependent on insulin-like growth factor I in vitro growth. Cancer Res. 1994;54:2803-2807.
18. Benini S, Baldini N, Manara MC, et al. Redundancy of autocrine loops in human osteosarcoma cells. Int J Cancer. 1990;80:581-588.
19. Dahlin DC, Unni KK. Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol. 1977;1:61-72.
20. Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr. 2002;56:171-180.
21. Pui CH, Dodge RK, George SL, et al. Height at diagnosis of malignancies. Arch Dis Child. 1987;62:495-499.
22. Price CHG. Primary bone-forming tumors and their relationship to skeletal growth. J Bone Joint Surg [Br]. 1958;40:574-593.
23. Cotterill SJ, Wright CM, Pearce MS, et al. Stature of young people with malignant bone tumors. Pediatr Blood Cancer. 2004;42:59-63.
24. Buckley JD, Pendergrass TW, Buckley CM, et al. Epidemiology of osteosarcoma and Ewing's sarcoma in childhood: a study of 305 cases by the Children's Cancer Group. Cancer. 1998;83:1440-1448.
25. Cooley DM, Beranek BC, Schlitter DL, et al. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1434-1440.
26. Rooks WH, Dorfman RJ. Estrogen radioprotection in mice. Endocrinology. 1961;68:838.
27. Highman B, Roth SI, Greenman DL. Osseous changes and osteosarcomas in mice continuously fed diets containing diethylstilbestrol or 17βestradiol. J Natl Cancer Inst. 1981;67:653-662.
28. 90Sr indiced osteosarcoma. Acta Oncol. 1988;27:393-398.
29. Weinfeld MS, Dudley HR. Osteogenic sarcoma. J Bone Joint Surg [Am]. 1962;44:269-272.
30. Glasser DB, Duane K, Lane JM, et al. The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop. 1991;262: 93-100.
31. Raile K, Hoflich A, Kessler U, et al. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor (IGF)-I receptors and IGF-II receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF receptor. J Cell Physiol. 1994;159:531-541.
32. Pinski J, Schally AV, Halmos G, et al. Inhibition of growth human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst. 1995;87:1787-1794.